AHA 2024 - Daniel Judge discusses the findings from the ATTRibute-CM-OLE trial, the open-label extension study of ATTRibute-CM with the oral TTR stabilizer acoramidis in patients with ATTR-CM.
Acoramidis reduces all-cause mortality in ATTR-CM
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
Educational information
This video was recorded during the AHA Scientific Sessions 2024 in Chicago, IL, US.
Faculty
Daniel Judge, MD is a professor of medicine in cardiology at Medical University of South Carolina (MUSC) in Charleston, SC, US.
Disclaimer
This recording was developed under auspices of PACE-CME. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-CME.
The findings of ATTRibute-CM-OLE have been published in Circulation
Release date: 18 November 2024
Overview
AHA 2024 - Daniel Judge discusses the findings from the ATTRibute-CM-OLE trial, the open-label extension study of ATTRibute-CM with the oral TTR stabilizer acoramidis in patients with ATTR-CM.
Educational information
This video was recorded during the AHA Scientific Sessions 2024 in Chicago, IL, US.
Faculty
Daniel Judge, MD is a professor of medicine in cardiology at Medical University of South Carolina (MUSC) in Charleston, SC, US.
Disclaimer
This recording was developed under auspices of PACE-CME. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-CME.
The findings of ATTRibute-CM-OLE have been published in Circulation
Release date: 18 November 2024
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Implementing a Multidisciplinary Approach to Heart Failure: Patient Identification and Treatment Using Novel Device Therapy
Advances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective
IgG4-RD Case Conversations: IgG4-related Autoimmune Pancreatitis and Cholangitis
Spinal Muscular Atrophy: Optimizing the Management of Adults in the Era of Disease-Modifying Therapies
TIME OUT: A Case-Based Deep Dive into the Challenges of ARIA Management
New Horizons: Unraveling Novel Therapies for Enhanced Cardiovascular Outcomes in Patients With Heart Failure
Partnering with Patients: Building Effective Communication and Support in HF Care
A Practical Guide to Prescribing in HF
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?